Abstract:There is continuing assessment to find the most effective management strategy for primary soft tissue sarcomas. The goal of treatment for any patient with malignant neoplasm is to provide a tumour-free survival without clinically appreciable treatment-related morbidity. For most adult patients, this currently is attempted by a combination of relatively conservative surgery and moderate dose of radiation. The concept being that radiation at dose levels of 50 to 60 Gy is adequate to inactivate the tumour cells which lie beyond the margins of a conservative resection, i.e., it replaces the resection of large volumes of normal tissue. Laboratory measurements of radiation sensitivity of cell lines derived from sarcomas of soft tissue tumours have shown that they are not radiation-resistant relative to the cell lines derived form epithelial tumours. Hence, there is no surprise the this combined modality approach has been demonstrated to be effective. The frequency of local control (85% to 90%) is at least as high as that combined by ablative surgery, but with much lesser decrement in functional and cosmetic status. Additionally, radiation at dose levels of about 75 Gy is effective in achieving worthwhile local control rates when administered against small sarcomas of the soft tissues, e.g. volumes of < or = 60 ml. Thus, for selected tumours, radiation alone does offer a reasonable option when surgery is not feasible for technical reasons or the patient is not operable for medical reasons. Available data do not indicate a clear advantage for adjuvant chemotherapy for this group of tumours. Trials are in progress to assess the efficacy of neo-adjuvant chemotherapy. We are conducting a phase II trial of MAID chemotherapy and radiation preoperatively; the results to date are superior to matched concurrently treated patients. For local therapy, high and approximately comparable local control rates are being reported for several approaches: radical compartmental resection for selected patients, surgery and postoperative radiation therapy, surgery and preoperative radiation treatment, resection and intraoperative placement of catheters for brachytherapy and intra-arterial adriamycin, radiation and resection. Our preferred approach for T 2, grades II-III sarcomas of the soft tissues is radiation prior to surgery. There are, however, no data on the functional and cosmetic status after treatment of patients whose sarcomas are of a specified site and volume for treatment by these diverse methods. This is a critically important question in the assessment of proper clinical role of each of these approaches.

The role of radiotherapy in the management of non‐melanoma skin cancer

Advanced skin squamous cell carcinoma: role of radiotherapy

Radiotherapy in the Treatment of Subcutaneous Melanoma

[New Radiation Therapy Concepts in Non-Metastatic Lung Cancer]

Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective

Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy

Indications and Outcomes of Radiation Therapy for Skin Cancer of the Head and Neck

Radiation and Melanoma: Where Are We Now?

The role of radiotherapy and chemotherapy for curative management of medically inoperable and stage III nonsmall cell lung cancer, and radiotherapy for palliation of symptomatic disease

Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities

Updates on the Management of Non-Melanoma Skin Cancer (NMSC)

Annals of Surgical Oncology Practice Guidelines Series: Adjuvant and Neoadjuvant Therapy for Melanoma

Beyond the Scalpel: Advancing Strategic Approaches and Targeted Therapies in Nonexcisable Melanomas

[What does the general and abdominal surgeon need to know about radiotherapy? - aspects of radiotherapy in general and abdominal surgery]

Current utilisation of advanced techniques and technologies in palliative radiation therapy in Australia and New Zealand

Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group

Radiotherapeutic advances in the management of glioblastoma

International Consensus on Radiotherapy in Metastatic Non-Small Cell Lung Cancer

Updates in the Management of Advanced Nonmelanoma Skin Cancer

Soft tissue sarcomas: radiation as a therapeutic option

[Rôle of radiotherapy for sarcomas]